SCHEMBL3536103

SCHEMBL3536103

COc1cc(C(=O)N2Cc3ccc(C(=O)NCc4cccc(C(F)(F)F)c4)n3Cc3ccccc32)ccc1-c1ccccc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.46
ROCK1 Q13464 2/20 0.46
PSEN1 P49768 1/20 0.45
PSEN2 P49810 1/20 0.45
APH1B Q8WW43 1/20 0.45
NCSTN Q92542 1/20 0.45
APH1A Q96BI3 1/20 0.45
PSENEN Q9NZ42 1/20 0.45
AVPR2 P30518 2/20 0.44
NPC1 O15118 1/20 0.43
THRB P10828 1/20 0.40
PTPN7 P35236 1/20 0.39
DUSP3 P51452 1/20 0.39
PPARG P37231 1/20 0.39
MAPK14 Q16539 1/20 0.39
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
BACE1 P56817 1/20 0.38
MLYCD O95822 1/20 0.38
HTR7 P34969 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3535503 0.93 HTR7 (0.42) ROCK2PSEN1PSEN2APH1BNCSTN
SCHEMBL3531258 0.91 THRB (0.48) ROCK2ROCK1AVPR2THRBLMNA
SCHEMBL3537560 0.91 AVPR2 (0.50) ROCK2ROCK1AVPR2THRBLMNA
SCHEMBL3536010 0.89 AVPR2 (0.47) AVPR2THRBLMNATP53AVPR1A
SCHEMBL3533374 0.88 AVPR2 (0.47) AVPR2THRBLMNATP53AVPR1A
SCHEMBL3533050 0.88 AVPR2 (0.44) ROCK2ROCK1AVPR2THRBLMNA
SCHEMBL3534647 0.88 ROCK2 (0.46) ROCK2ROCK1AVPR2LMNAAVPR1A
SCHEMBL3534697 0.87 AVPR2 (0.47) AVPR2THRBLMNATP53HTR7
SCHEMBL3533432 0.87 AVPR2 (0.47) ROCK2ROCK1AVPR2THRBLMNA
SCHEMBL3535538 0.87 MAPT (0.47) ROCK2ROCK1AVPR2THRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691848-B2 Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists WYETH (US) 2010-04-06 US claimed
US-20060199806-A1 Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists WYETH (US) 2006-09-07 US claimed
US-7691848-B2 Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists WYETH (US) 2010-04-06 US disclosed
US-20060199806-A1 Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists WYETH (US) 2006-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060199806-A1 Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists FSHR, GNRHR, LHCGR ROCK2 4411/4885ROCK1 4667/4885PSEN1 2924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.